[Code of Federal Regulations]
[Title 21, Volume 7]
[Revised as of April 1, 2001]
From the U.S. Government Printing Office via GPO Access
[CITE: 21CFR640.4]

[Page 86-87]
 
                        TITLE 21--FOOD AND DRUGS
 
          DEPARTMENT OF HEALTH AND HUMAN SERVICES--(Continued)
 
PART 640--ADDITIONAL STANDARDS FOR HUMAN BLOOD AND BLOOD PRODUCTS--Table of Contents
 
                         Subpart A--Whole Blood
 
Sec. 640.4  Collection of the blood.

    (a) Supervision. Blood shall be drawn from the donor by a qualified 
physician or under his supervision by assistants trained in the 
procedure. A physician shall be present on the premises when blood is 
being collected, except that blood may be collected when a physician is 
not present on the premises, provided the establishment (1) maintains on 
the premises, and files with the Center for Biologics Evaluation and 
Research, a manual of standard procedures and methods, approved by the 
Director of the Center for Biologics Evaluation and Research, that shall 
be followed by employees who collect blood, and (2) maintains records 
indicating the name and qualifications of the person immediately in 
charge of the employees who collect blood when a physician is not 
present on the premises.
     (b) The donor center. The pertinent requirements of Secs. 600.10 
and 600.11 of this chapter shall apply at both the blood establishment 
and at any other place where the bleeding is performed.
    (c) Blood containers. Blood containers and donor sets shall be 
pyrogen-free, sterile and identified by lot number. The amount of 
anticoagulant required for the quantity of blood to be collected shall 
be in the blood container when it is sterilized. In addition, all 
container and donor set surfaces that come in contact with blood used in 
the processing of Heparin Whole Blood shall be water repellent.
     (d) The anticoagulant solution. The anticoagulant solution shall be 
sterile and pyrogen-free. Anticoagulant solutions shall be compounded 
and used according to a formula approved by the Director, Center for 
Biologics Evaluation and Research.
    (e) Donor identification. Each unit of blood shall be so marked or 
identified by number or other symbol as to relate it to the individual 
donor whose identity shall be established to the extent necessary for 
compliance with Sec. 640.3.
    (f) Prevention of contamination of the blood. The skin of the donor 
at the site of phlebotomy shall be prepared thoroughly and carefully by 
a method that gives maximum assurance of a sterile container of blood. 
The blood shall be collected by aseptic methods in a sterile system 
which may be closed or may be vented if the vent protects the blood 
against contamination.
    (g) Pilot samples for laboratory tests. Pilot samples for laboratory 
tests shall meet the following standards:
    (1) One or more pilot samples shall be provided with each unit of 
blood when issued or reissued except as provided in Sec. 640.2(c)(2) and 
all pilot samples shall be from the donor who is the source of the unit 
of blood.
    (2) All samples for laboratory tests performed by the manufacturer 
and all pilot samples accompanying a unit of blood shall be collected at 
the time of filling the final container by the person who collects the 
unit of blood.
    (3) All containers for all samples shall bear the donor's 
identification before collecting the samples.
    (4) All containers for pilot samples accompanying a unit of blood 
shall be attached to the whole blood container before blood collection 
in a tamperproof manner that will conspicuously indicate removal and 
reattachment.
    (5) When CPDA-1 is used, pilot samples for compatibility testing 
shall contain blood mixed with CPDA-1.
    (h) Storage. Immediately after collection, unless the blood is to be 
used as a source for Platelets, it shall be placed in storage at a 
temperature between 1 and 6  deg.C unless it must be transported from 
the donor clinic to the processing laboratory. In the latter case, the 
blood shall be placed in temporary storage having sufficient 
refrigeration capacity to cool the blood continuously toward a range 
between 1 and 6  deg.C until it arrives at the processing laboratory, 
where it shall be stored at a temperature between 1 and 6  deg.C. Blood 
from which Platelets is to be prepared shall be held in an environment 
maintained at a temperature range 20 to 24  deg.C until the platelets 
are separated. The red blood cells shall be placed in storage at

[[Page 87]]

a temperature between 1 and 6  deg.C immediately after the platelets are 
separated.

[38 FR 32089, Nov. 20, 1973, as amended at 42 FR 59878, Nov. 22, 1977; 
43 FR 34460, Aug. 4, 1978; 49 FR 23834, June 8, 1984; 50 FR 4138, Jan. 
29, 1985; 55 FR 11013, Mar. 26, 1990; 64 FR 45372, Aug. 19, 1999; 66 FR 
1836, Jan. 10, 2001]